Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Patients with locoregionally advanced Nasopharyngeal carcinoma (NPC) / Nasopharynx cancer are at high risk of disease recurrence, although a high proportion of patients will achieve complete response (CR) after Chemoradiotherapy (CRT) with or without induction chemotherapy. Additional adjuvant therapies are required to reduce the risk of recurrence and death further. However, the benefit of adjuvant chemotherapy for Nasopharyngeal carcinoma (NPC) / Nasopharynx cancer remains controversial.
Chen et al. 2021h The lancet 398: 303-313
The tumour-node-metastasis (TNM) staging system is an essential tool to…